Health
Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults – DocWire News
Nature. 2020 Aug 12. doi: 10.1038/s41586-020-2639-4. Online ahead of print.ABSTRACTIn March 2020, the World Health Organization (WHO) declared a pandemic
Nature. 2020 Aug 12. doi: 10.1038/s41586-020-2639-4. Online ahead of print.
ABSTRACT
In March 2020, the World Health Organization (WHO) declared a pandemic of coronavirus disease 2019 (COVID-19), due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)1. With rapidly accumulating cases and deaths reported globally2, a vaccine is urgently needed. We report the available safety, tolerability, and immunogenicity data from an ongoing placebo-controlled, observer-blinded dose escalation …
-
Business16 hours ago10 ASX shares to buy after the market selloff
-
General19 hours ago‘We are here for you’: PM to bring help to flood zones
-
Business15 hours ago$10,000 invested in ANZ shares 5 years ago is now worth…
-
General18 hours agoWe’ve all talked about potential economic consequences for Australia of Trump’s policies. Now they’re happening